Clinical Assessment And Treatment Preferences of Physiotherapists Working in Neurorehabilitation: A Research From Turkey

February 12, 2024 updated by: Guzin Kaya Aytutuldu, Biruni University
The most common neurological diseases are stroke, Multiple Sclerosis and Parkinson's. Neurorehabilitation is a process that aims to improve the quality of life by minimizing the functional disorders caused by the motor and sensory effects of the problems in the nervous system. A detailed and accurate evaluation and an effective treatment program are required for successful neurorehabilitation. There is no common perspective on evaluation and treatment methods used in the field of neurorehabilitation.The aim of this study is to establish a standard perspective by determining the most preferred evaluation and treatment methods by physiotherapists working in the field of neurorehabilitation in our country. This perspective will help to establish a common understanding in the field of neurorehabilitation and to have knowledge of the different methods used by all physiotherapists working in this field. In this way, the treatment process of the patients will become more effective, and the results obtained from the treatment will be reflected positively. This study will be a resource showing the evaluation methods and preferences of physiotherapists working in the field of neurorehabilitation in Turkey.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Rehabilitation is a part of health services performed in many diseases and specific areas. It has four stages, and these are prevention, enhancement, treatment and protection. The main purpose of rehabilitation programs is independence in activities. It is to increase the quality of life and social adaptation of the patient by protecting the patient, minimizing pain and disability, and improving the ability to adapt to changing conditions. Neurological problems are one of the areas that often need rehabilitation. Millions of people worldwide are affected by neurodegenerative problems. According to the data shared by the World Health Organization (WHO), many of the neurological disorders are chronic and progressive, creating a global picture. Neurological problems negatively affect the health of the individual in many ways. To improve the physical and emotional functions, quality of life and social participation levels of individuals with neurological disease, it is necessary to know the limitations they experience due to neurological disease very well. The causes of neurological problems can vary from person to person and from problem to problem. These causes may include genetic disorders, congenital abnormalities or disorders, infections, lifestyle, or environmental health issues, including malnutrition, brain injury, spinal cord injury, nerve injury [8,9]. In addition, the neurological problem may begin in another system that interacts with the nervous system. For example, stroke (cerebrovascular accident), includes brain damage caused by problems with the blood vessels that feed the brain (cardiovascular system); autoimmune disorders, caused by the body's own immune system includes damage. Neurological diseases bring with them secondary problems besides primary problems. These secondary problems and deformities negatively affecting function, productivity and participation, which are essential components of their activities, restricts the independence of the individual. Pertaining to the motor and sensory systems seen in neurological diseases. The problems are often accompanied by cognitive, behavioural, sensory, communication and perception disorders. is seen. It is known that participation in daily life activities is one of the elements that increase the creativity of individuals, improve their skills and enable them to integrate into social life .By identifying the limitations experienced by individuals due to neurological disease. Improving their quality of life and social participation levels is the most basic of rehabilitation is the target. The most common neurological diseases are stroke, Multiple Sclerosis and Parkinson's. Neurorehabilitation is a process that aims to improve the quality of life by minimizing the functional disorders caused by the motor and sensory effects of the problems in the nervous system. A detailed and accurate evaluation and an effective treatment program are required for successful neurorehabilitation.There is no common perspective on evaluation and treatment methods used in the field of neurorehabilitation.The purpose of this study is to establish a standard perspective by determining the most preferred evaluation and treatment methods by physiotherapists working in the field of neurorehabilitation in our country. This perspective will help to establish a common understanding in the field of neurorehabilitation and to have knowledge of the different methods used by all physiotherapists working in this field. In this way, the treatment process of the patients will become more effective, and the results obtained from the treatment will be reflected positively. This study will be a resource showing the evaluation methods and preferences of physiotherapists working in the field of neuro rehabilitation in Turkey.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
95

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Turkey
    • Ataşehir
      • İstanbul, Ataşehir, Turkey, 34752
        • Biruni University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Physiotherapists who can read and understand Turkish and have at least three years of work experience will be included in the study. It is planned to send the questionnaire prepared via Google Survey to physiotherapists working in the field via non-governmental organizations, social media and association mails. In the questionnaire, it was aimed to question the age, gender, duration of work in the profession, the duration of work in the field of neurorehabilitation, the training received after graduation, the most preferred evaluation and treatment methods for neurological diseases that are mostly encountered in the field.

Description

Inclusion Criteria:

  • Having at least 3 years of patient follow-up experience in the field of neurorehabilitation
  • Men and women of all age groups who are in the active working process physiotherapists
  • Being a volunteer
  • Speaks and understands the Turkish language (for foreign nationals)

Exclusion Criteria:

  • Respondents who did not or incompletely answered parts of the survey

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Google Form Questionnaire
Time Frame: 5 minutes
It is planned to send the questionnaire prepared via Google Questionnaire to the physiotherapists who accept to participate in the research and meet the inclusion criteria, to the physiotherapists working in the field via social media, the Physiotherapists Association of Turkey and its sub-groups registered members after the necessary permissions are obtained.
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Biruni University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Guzin Kaya Aytutuldu, Biruni University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
April 17, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
April 24, 2023

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 30, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
May 3, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 3, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
May 11, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
February 14, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 12, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
February 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • Biruni Un

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings